Showing results (101-110 of 157) with videos related to
Sort By:
Pageof 16
Journal of Psychiatric Research|March 11, 2021
The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic reviewJoshua D Di Vincenzo, Ashley Siegel, Orly Lipsitz, et al.Acta Neuropsychiatrica|February 14, 2025
Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic reviewHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.Advances in Therapy|April 30, 2021
Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant DepressionEric P McMullen, Yena Lee, Orly Lipsitz, et al.Journal of Affective Disorders|September 20, 2024
Association between rumination, suicidal ideation and suicide attempts in persons with depressive and other mood disorders and healthy controls: A systematic review and meta-analysisGia Han Le, Sabrina Wong, Hezekiah Au, et al.Journal of Psychiatric Research|November 2, 2025
The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: A systematic reviewIsabella S Ji, Morgan C H Cheng, Kayla M Teopiz, et al.Psychoneuroendocrinology|April 3, 2026
The effect of GLP-1 receptor agonists on anxiety: A systematic reviewYu Tian Yi, Yang Jing Zheng, Stavroula I Bargiota, et al.Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.Journal of Affective Disorders|October 17, 2025
Effects of glutamatergic modulators on striatal activation, functional connectivity and reward in persons with major depressive disorder and healthy controls: A systematic review of fMRI studiesKayla M Teopiz, Sabrina Wong, Gia Han Le, et al.Psychiatry Research|December 10, 2021
Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellenceJoshua D Di Vincenzo, Orly Lipsitz, Nelson B Rodrigues, et al.Expert Opinion on Drug Safety|April 15, 2022
Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatmentMarcus A Doyle, Susan Ling, Leanna M W Lui, et al.Pageof 16